Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
about
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerSalpingectomy as a means to reduce ovarian cancer riskRationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidencePathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis.New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future researchOpportunistic salpingectomy for ovarian cancer preventionPAX8 expression in ovarian surface epithelial cellsGenetic risk and gynecologic cancers.Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions.
P2860
Q27009306-3C733CDF-275D-4935-9F90-0380EC31C9DCQ27011949-E3B72524-104C-4FB6-A059-F2F1E6FBF474Q30250107-34E7FEDD-8379-4B03-BC57-AA7751701860Q30370475-F6F2DF4A-A590-4723-82A3-3C9801D9080CQ33668934-3542F988-415B-49EA-8183-7A9AE4F061CDQ34209092-D766538D-C33C-470E-B0DE-F16F898274C3Q34543315-59208D4C-F373-46E9-9F47-126A9FC822B0Q36938143-F477D2E7-7A32-4EF4-AFF0-0EA3AFE3F758Q37109448-AFDB3A2A-D863-467E-AD8E-CDFB41650A82Q37468316-469A34AC-00A2-4E1C-87E0-16E6C377BBAEQ37553978-589B1DDD-A396-4D63-A289-9F34F97C7E8EQ38732720-21A1D9A6-379C-4CD6-9193-3CE08A045A3DQ40274074-DDC24C13-6313-450A-AFAF-AF1DF9687755Q46581570-D782571C-5035-482D-959C-21D8578A8B30Q49184692-10278588-5D66-4003-B933-8B836701F567
P2860
Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@ast
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@en
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@nl
type
label
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@ast
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@en
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@nl
prefLabel
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@ast
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@en
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@nl
P2093
P2860
P1476
Microscopic and early-stage ov ...... BRCA-associated tumorigenesis.
@en
P2093
David M Gershenson
Elizabeth R Keeler
Karen H Lu
Larissa A Meyer
Melinda S Yates
Michael T Deavers
Samuel C Mok
P2860
P304
P356
10.1158/1940-6207.CAPR-10-0266
P577
2011-01-28T00:00:00Z